Manon Reda

Dijon, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Prevalence, clinicopathologic features and long-term overall survival of early breast cancer patients eligible for adjuvant abemaciclib and/or ribociclib.

Prevalence, clinicopathologic features and long-term overall survival of early breast cancer patients eligible for adjuvant abemaciclib and/or ribociclib.

Journal: NPJ breast cancer

Published: November 01, 2024

Real-world prevalence, treatment and survival of "high risk" early breast cancer, with mandatory testing of gBRCA1/2 mutation according to the OlympiA trial inclusion criteria: Data from a population-based registry.

Real-world prevalence, treatment and survival of "high risk" early breast cancer, with mandatory testing of gBRCA1/2 mutation according to the OlympiA trial inclusion criteria: Data from a population-based registry.

Journal: Breast (Edinburgh, Scotland)

Published: July 02, 2024

Neurodevelopmental and other phenotypes recurrently associated with heterozygous BAZ2B loss-of-function variants.

Neurodevelopmental and other phenotypes recurrently associated with heterozygous BAZ2B loss-of-function variants.

Journal: American journal of medical genetics. Part A

Published: June 13, 2023

Advancing precision oncology through systematic germline and tumor genetic analysis: The oncogenetic point of view on findings from a prospective multicenter clinical trial of 666 patients.

Advancing precision oncology through systematic germline and tumor genetic analysis: The oncogenetic point of view on findings from a prospective multicenter clinical trial of 666 patients.

Journal: Cancer medicine

Published: May 02, 2023

Low risk of embryonic and other cancers in PIK3CA-related overgrowth spectrum: Impact on screening recommendations.

Low risk of embryonic and other cancers in PIK3CA-related overgrowth spectrum: Impact on screening recommendations.

Journal: Clinical genetics

Published: December 23, 2022

Clinical Utility of Genomic Tests Evaluating Homologous Recombination Repair Deficiency (HRD) for Treatment Decisions in Early and Metastatic Breast Cancer.

Clinical Utility of Genomic Tests Evaluating Homologous Recombination Repair Deficiency (HRD) for Treatment Decisions in Early and Metastatic Breast Cancer.

Journal: Cancers

Published: December 13, 2022

Taxane rechallenge during metastatic disease in HER-2 negative breast cancer patients: Clinical activity, tolerance and survival results.

Taxane rechallenge during metastatic disease in HER-2 negative breast cancer patients: Clinical activity, tolerance and survival results.

Journal: Breast (Edinburgh, Scotland)

Published: October 14, 2022

Detection of relevant pharmacogenetic information through exome sequencing in oncology.

Detection of relevant pharmacogenetic information through exome sequencing in oncology.

Journal: Pharmacogenomics

Published: August 31, 2022

Optimization of G-CSF dosing schedule in patients treated with eribulin: a modeling approach.

Optimization of G-CSF dosing schedule in patients treated with eribulin: a modeling approach.

Journal: Cancer chemotherapy and pharmacology

Published: September 08, 2021

Implementation and use of whole exome sequencing for metastatic solid cancer.

Implementation and use of whole exome sequencing for metastatic solid cancer.

Journal: EBioMedicine

Published: August 28, 2019

Anti-MEK and Anti-EGFR mAbs in RAS-Mutant Metastatic Colorectal Cancer: Case Series and Rationale.

Anti-MEK and Anti-EGFR mAbs in RAS-Mutant Metastatic Colorectal Cancer: Case Series and Rationale.

Journal: Advances in therapy

Published: February 04, 2019

Showing 1-11 of 11

Last Updated: 09/26/2026